Article info
PDFClinical and epidemiological research
Concise report
Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis
- Correspondence to Dr B J Radovits, Radboud University Nijmegen Medical Centre, Department of Rheumatology, PO Box 9101, Hp 470, 6500 HB Nijmegen, The Netherlands; B.Radovits{at}reuma.umcn.nl
Citation
Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis
Publication history
- Accepted November 3, 2008
- First published November 17, 2008.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd and European League Against Rheumatism. All rights reserved.